BAKER BROS. ADVISORS LP Q2 2019 Filing

Filed August 14, 2019

Portfolio Value

$14.7B

Holdings

103

Report Date

Q2 2019

Filing Type

13F-HR

All Holdings (103 positions)

#StockSharesValue% PortfolioType
101
—Ritter Pharmaceuticals, Inc.
279,999$300.0M2.04%
102
DVAXDynavax Technologies Corporation
75,000$299.0M2.03%
103
TREURTrillium Therapeutics Inc.
505,262$166.0M1.13%
PreviousPage 2 of 2